Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction.
about
Genetic, hormonal and metabolic aspects of PCOS: an updateA Comparison of 2-Methoxyestradiol Value in Women with Severe Preeclampsia Versus Normotensive Pregnancy.G-protein-coupled receptor 30 mediates the effects of estrogen on endothelial cell tube formation in vitro.Higher estrogen levels during pregnancy in Andean than European residents of high altitude suggest differences in aromatase activity2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia.Estrogen Replacement Therapy in Ovariectomized Nonpregnant Ewes Stimulates Uterine Artery Hydrogen Sulfide Biosynthesis by Selectively Up-Regulating Cystathionine β-Synthase Expression.Systematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the DiseaseDecreased expression and DNA methylation levels of GATAD1 in preeclamptic placentasOntogeny of polycystic ovary syndrome and insulin resistance in utero and early childhoodIdentification of Differential ER-Alpha Versus ER-Beta Mediated Activation of eNOS in Ovine Uterine Artery Endothelial CellsChronic hypoxia inhibits pregnancy-induced upregulation of SKCa channel expression and function in uterine arteries.Neutrophils induce proangiogenic T cells with a regulatory phenotype in pregnancy.Local effects of pregnancy on connexin proteins that mediate Ca2+-associated uterine endothelial NO synthesis.Gap junction regulation of vascular tone: implications of modulatory intercellular communication during gestation.SRC-3 Plays a Critical Role in Human Umbilical Vein Endothelial Cells by Regulating the PI3K/Akt/mTOR Pathway in Preeclampsia.Leptin-promoted human extravillous trophoblast invasion is MMP14 dependent and requires the cross talk between Notch1 and PI3K/Akt signaling.Preeclampsia Downregulates MicroRNAs in Fetal Endothelial Cells: Roles of miR-29a/c-3p in Endothelial Function.Association of a reduction of G‑protein coupled receptor 30 expression and the pathogenesis of preeclampsia.Preeclampsia and maternal risk of breast cancer: a meta-analysis of cohort studies.Angiogenesis during pregnancy: all routes lead to MAPKs.Convergent ERK1/2, p38 and JNK mitogen activated protein kinases (MAPKs) signalling mediate catecholoestradiol-induced proliferation of ovine uterine artery endothelial cells.Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.Estradiol decreases blood pressure in association with redox regulation in preeclampsia.
P2860
Q26740034-BD3478AA-00F5-4C21-ACF3-254F13FC13B4Q33666763-DA19054D-7338-4746-B14F-069D7C335F0AQ33674855-7ECCCF53-FA86-429B-AC9B-8B376B22DD14Q33999034-6B836C19-2C99-4902-9BC1-6B47F5F65A64Q34876226-F46F294A-CC8A-4CF9-80E8-E05608C64605Q35603320-9D5556DF-18D3-4838-B86A-3F5DD94DF82EQ36104833-91B3A9F8-A257-4748-8E6C-CA7837D9EAE8Q36278753-E73D6A7E-EA50-4771-AE60-9EC4F446E415Q37067105-0705D138-51AB-4CAA-8169-5111AE6D3F56Q37098541-6A9F3755-AA8E-44E5-B4B5-373D13E54717Q37249674-43F47C38-D09F-4F55-998C-327D31297828Q37549928-189F534C-5C47-4AB2-87C7-7CE834E5DC18Q37622380-F820E0D1-000C-4CDC-BAB2-52B465AFD77CQ38228606-6F7E73BA-FCAE-4AB6-B264-652F71D57D3FQ38615970-A13531AA-E3CF-4148-8FD4-90CB65AD61C6Q39020720-F6BD593C-AE45-43C0-A189-6A6519A572FBQ40040729-2C8CB2E4-4C58-4B97-BD07-D98DFC0B5377Q46302960-1605B341-DD99-498C-9E87-2573456ECECCQ47695596-CDC7771C-D25F-4BE1-AECE-103364AD003FQ48132339-D502EB6E-90ED-4719-88FE-CF6A71678BD4Q48239999-957D33C7-9EE1-4402-AC4D-B452DCF170F9Q49887672-FB689AC3-9645-43DF-9C6A-1F0117AFEE6DQ50048635-2362204B-08DA-4B0B-AA0C-9AABC8A09156
P2860
Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Aberrant synthesis, metabolism ...... ions for vascular dysfunction.
@en
type
label
Aberrant synthesis, metabolism ...... ions for vascular dysfunction.
@en
prefLabel
Aberrant synthesis, metabolism ...... ions for vascular dysfunction.
@en
P2093
P2860
P921
P1433
P1476
Aberrant synthesis, metabolism ...... ions for vascular dysfunction.
@en
P2093
Chanel T Tyler
Ronald R Magness
Sheikh O Jobe
P2860
P304
P356
10.1161/HYPERTENSIONAHA.111.201624
P407
P577
2013-01-14T00:00:00Z